Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000899243-22-026903

Options or other derivatives

  • Director acquired 71,881 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kathiresan Sekar · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +71,881 71,881 D
Loading xslF345X03/doc4.xml…